Edition:
United Kingdom

Halozyme Therapeutics Inc (HALO.OQ)

HALO.OQ on NASDAQ Stock Exchange Global Select Market

15.30USD
5:08pm GMT
Change (% chg)

$0.05 (+0.33%)
Prev Close
$15.25
Open
$15.13
Day's High
$15.52
Day's Low
$15.11
Volume
47,130
Avg. Vol
298,397
52-wk High
$21.47
52-wk Low
$14.33

Chart for

About

Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing oncology therapies. The Company operates in research, development and commercialization of human enzymes and other drug candidates. The Company's segment also includes research and development activities and product sales of Hylenex... (more)

Overall

Beta: 2.08
Market Cap(Mil.): $2,435.27
Shares Outstanding(Mil.): 141.92
Dividend: --
Yield (%): --

Financials

  HALO.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.92 -- --
ROI: -46.20 9.01 14.96
ROE: -352.48 10.15 16.52

BRIEF-Halozyme licenses new enhanze targets for $25 million upfront payment, future milestones and royalties

* HALOZYME LICENSES NEW ENHANZE TARGETS FOR $25 MILLION UPFRONT PAYMENT, FUTURE MILESTONES AND ROYALTIES

30 Oct 2018

Earnings vs. Estimates